{
  "form": "10-K",
  "filing_date": "2025--",
  "accession_number": "0000950170-25-047740",
  "company_name": "Company Name",
  "filing_url": "https://www.sec.gov/Archives/edgar/data/0000950170-25-047740",
  "content": "<SEC-DOCUMENT>0000950170-25-047740.txt : 20250331\n<SEC-HEADER>0000950170-25-047740.hdr.sgml : 20250331\n<ACCEPTANCE-DATETIME>20250331161537\nACCESSION NUMBER:\t\t0000950170-25-047740\nCONFORMED SUBMISSION TYPE:\t10-K\nPUBLIC DOCUMENT COUNT:\t\t120\nCONFORMED PERIOD OF REPORT:\t20241231\nFILED AS OF DATE:\t\t20250331\nDATE AS OF CHANGE:\t\t20250331\n\nFILER:\n\n\tCOMPANY DATA:\t\n\t\tCOMPANY CONFORMED NAME:\t\t\tRani Therapeutics Holdings, Inc.\n\t\tCENTRAL INDEX KEY:\t\t\t0001856725\n\t\tSTANDARD INDUSTRIAL CLASSIFICATION:\tPHARMACEUTICAL PREPARATIONS [2834]\n\t\tORGANIZATION NAME:           \t03 Life Sciences\n\t\tEIN:\t\t\t\t000000000\n\t\tSTATE OF INCORPORATION:\t\t\tDE\n\t\tFISCAL YEAR END:\t\t\t1231\n\n\tFILING VALUES:\n\t\tFORM TYPE:\t\t10-K\n\t\tSEC ACT:\t\t1934 Act\n\t\tSEC FILE NUMBER:\t001-40672\n\t\tFILM NUMBER:\t\t25793451\n\n\tBUSINESS ADDRESS:\t\n\t\tSTREET 1:\t\t2051 RINGWOOD AVENUE\n\t\tCITY:\t\t\tSAN JOSE\n\t\tSTATE:\t\t\tCA\n\t\tZIP:\t\t\t95131\n\t\tBUSINESS PHONE:\t\t(408) 457-3700\n\n\tMAIL ADDRESS:\t\n\t\tSTREET 1:\t\t2051 RINGWOOD AVENUE\n\t\tCITY:\t\t\tSAN JOSE\n\t\tSTATE:\t\t\tCA\n\t\tZIP:\t\t\t95131\n</SEC-HEADER>\n<DOCUMENT>\n<TYPE>10-K\n<SEQUENCE>1\n<FILENAME>rani-20241231.htm\n<DESCRIPTION>10-K\n<TEXT>\n<XBRL>\n<?xml version='1.0' encoding='ASCII'?>\n<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->\n<!-- Creation Date :2025-03-31T09:59:05.9731+00:00 -->\n<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:xbrldi=\"http://xbrl.org/2006/xbrldi\" xmlns:xbrldt=\"http://xbrl.org/2005/xbrldt\" xmlns:xbrli=\"http://www.xbrl.org/2003/instance\" xmlns:link=\"http://www.xbrl.org/2003/linkbase\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:ix=\"http://www.xbrl.org/2013/inlineXBRL\" xmlns:nonNumeric=\"http://www.xbrl.org/dtr/type/non-numeric\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:dei=\"http://xbrl.sec.gov/dei/2024\" xmlns:us-gaap=\"http://fasb.org/us-gaap/2024\" xmlns:iso4217=\"http://www.xbrl.org/2003/iso4217\" xmlns:ecd=\"http://xbrl.sec.gov/ecd/2024\" xmlns:dtr-types=\"http://www.xbrl.org/dtr/type/2022-03-31\" xmlns:rani=\"http://www.ranitherapeutics.com/20241231\" xmlns:cyd=\"http://xbrl.sec.gov/cyd/2024\" xmlns:ixt-sec=\"http://www.sec.gov/inlineXBRL/transformation/2015-08-31\" xmlns:ecd-sub=\"http://xbrl.sec.gov/ecd-sub/2024\" xmlns:ixt=\"http://www.xbrl.org/inlineXBRL/transformation/2022-02-16\" xmlns:srt=\"http://fasb.org/srt/2024\" xmlns:utr=\"http://www.xbrl.org/2009/utr\">\n <head>\n  <title>10-K</title>\n  <meta http-equiv=\"Content-Type\" content=\"text/html\"/>\n </head>\n <body style=\"padding:8px;margin:auto!important;\">\n  <div style=\"display:none;\"><ix:header><ix:hidden><ix:nonNumeric id=\"F_4e39fe1a-d14c-4810-8a82-2d40130e169d\" name=\"dei:CurrentFiscalYearEndDate\" contextRef=\"C_4448f038-b8c5-4cee-ad28-a1e6e6f0822c\">--12-31</ix:nonNumeric><ix:nonNumeric id=\"F_5b7da8f0-ea9f-4de2-a0da-7f5702e3dbe1\" name=\"dei:DocumentFiscalPeriodFocus\" contextRef=\"C_4448f038-b8c5-4cee-ad28-a1e6e6f0822c\">FY</ix:nonNumeric><ix:nonNumeric id=\"F_3e246a1a-ab89-4987-9939-31e88d1112dd\" name=\"dei:EntityCentralIndexKey\" contextRef=\"C_4448f038-b8c5-4cee-ad28-a1e6e6f0822c\">0001856725</ix:nonNumeric><ix:nonNumeric id=\"F_f83bceb2-cca9-4642-b947-e6b25cf573cb\" name=\"dei:AmendmentFlag\" contextRef=\"C_4448f038-b8c5-4cee-ad28-a1e6e6f0822c\">false</ix:nonNumeric><ix:nonFraction id=\"F_d95893f1-d2d1-4d0c-8aab-c7b90657488a\" name=\"us-gaap:CommitmentsAndContingencies\" contextRef=\"C_6cf9af2f-b8b5-4ffd-ba42-fea54c838353\" unitRef=\"U_USD\" xsi:nil=\"true\"></ix:nonFraction><ix:nonFraction id=\"F_01fcc02c-b824-430e-9bf5-d3bb10fd20ae\" name=\"us-gaap:CommitmentsAndContingencies\" contextRef=\"C_46b80544-8c15-4028-9906-f48781fb2e13\" unitRef=\"U_USD\" xsi:nil=\"true\"></ix:nonFraction><ix:nonNumeric id=\"F_bb25d922-92ca-4c3b-9359-12856f448fd7\" name=\"dei:EntityIncorporationDateOfIncorporation\" contextRef=\"C_4448f038-b8c5-4cee-ad28-a1e6e6f0822c\">2021-04-06</ix:nonNumeric><ix:nonFraction id=\"F_ca140d6c-9220-4d83-9d10-0725cd3813e4\" name=\"us-gaap:OtherPrepaidExpenseCurrent\" contextRef=\"C_6cf9af2f-b8b5-4ffd-ba42-fea54c838353\" unitRef=\"U_USD\" decimals=\"-6\" scale=\"6\" format=\"ixt:num-dot-decimal\">0</ix:nonFraction><ix:nonNumeric id=\"F_4cff8bf0-8b30-48c5-ac83-6844c738716b\" name=\"rani:WarratsExpirationTerm\" contextRef=\"C_f4c82b77-5780-4c13-b533-b22a21543354\" format=\"ixt-sec:duryear\">5.6</ix:nonNumeric><ix:nonNumeric id=\"F_89b74c54-122b-46ca-a95d-18b1f52adc31\" name=\"us-gaap:TaxCreditCarryforwardExpirationDate\" contextRef=\"C_77df8882-0d13-4ba2-80c3-479a8d7ed03f\">2041-12-31</ix:nonNumeric><ix:nonNumeric id=\"F_a70bb7ca-e593-415f-a5b2-bdca6abc6926\" name=\"us-gaap:TaxCreditCarryforwardExpirationDate\" contextRef=\"C_649fa05e-49e4-4deb-88ec-dafce39ca51d\">2044-12-31</ix:nonNumeric><ix:nonNumeric id=\"F_21908204-6a47-4c75-9b34-b0b9dbcb71a2\" name=\"us-gaap:TaxCreditCarryforwardExpirationDate\" contextRef=\"C_7321108a-2ffa-40f0-88c1-d393cbe00dd6\">2041-12-31</ix:nonNumeric><ix:nonNumeric id=\"F_a493595a-8d03-461f-bf40-57e76d8037a0\" name=\"us-gaap:TaxCreditCarryforwardExpirationDate\" contextRef=\"C_0aa43065-66fc-4844-bb78-5312649ad11d\">2044-12-31</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type=\"simple\" xlink:href=\"rani-20241231.xsd\"/></ix:references><ix:resources><xbrli:context id=\"C_819fa06f-06c9-4ccf-b6b9-d182de1a8d40\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"srt:ConsolidatedEntitiesAxis\">rani:RaniLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id=\"C_8291d6da-4a4f-4a73-970e-efa0142a83f5\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"us-gaap:StatementEquityComponentsAxis\">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension=\"us-gaap:StatementClassOfStockAxis\">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id=\"C_82d8e02b-0641-4e89-af5f-143e2ca3be58\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"us-gaap:FairValueByFairValueHierarchyLevelAxis\">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension=\"us-gaap:FinancialInstrumentAxis\">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension=\"us-gaap:FairValueByMeasurementFrequencyAxis\">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id=\"C_83a1c1bd-d12b-40f9-8432-6258f5c5dc08\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"us-gaap:AwardTypeAxis\">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id=\"C_84bf7df6-5acc-49ac-b0ad-51e16d766512\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"us-gaap:PropertyPlantAndEquipmentByTypeAxis\">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id=\"C_857cf929-d557-4e76-bf20-4407724449d1\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"us-gaap:StatementEquityComponentsAxis\">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension=\"us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis\">us-gaap:SeriesAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension=\"us-gaap:StatementClassOfStockAxis\">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id=\"C_858dc528-3856-4da9-b4d1-59748028e9bd\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"us-gaap:DebtInstrumentAxis\">rani:AvenueVentureOpportunityFundLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension=\"us-gaap:FinancialInstrumentAxis\">rani:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id=\"C_86ddeb41-31b0-4fa7-8e50-b099bf7c1fdf\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"us-gaap:FairValueByAssetClassAxis\">rani:RestrictedCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension=\"us-gaap:FinancialInstrumentAxis\">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id=\"C_874527a4-c7b8-43e9-8a41-9c119b71f95b\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id=\"C_87a6b49f-0541-437f-a72f-d61c7fc07990\"><xbrli:entity><xbrli:identifier scheme=\"http://www.sec.gov/CIK\">0001856725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension=\"us-gaap:PlanNameAxis\">rani:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimensi"
}